secwatch / observer
8-K filed December 28, 2023, 6:59 PM ET CIK 0001848861
leadership confidence high sentiment neutral materiality 0.60

Healthcare AI Acquisition Corp. announces board and CEO change effective Dec. 28, 2023

Healthcare AI Acquisition Corp.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Xiaocheng Peng

Chief Financial Officer
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
Xiaocheng Peng, will become the permanent chief financial officer of the Company and non-independent director.
Appointed

Nat Y Chan

Director
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
Departed

Yuerong Tan

Director
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
Appointed

Jiande Chen

Chairman of the Board
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
Jiande Chen will replace Zikang Wu as Chief Executive Officer of the Company and chairman of the Board.
Departed

Zikang Wu

Chief Executive Officer
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Successor
Jiande Chen
Filed
December 28, 2023, 6:59 PM ET
Zikang Wu shall resign as chief executive officer, to be effective upon the expiration of all applicable waiting periods under Section 14(f) of the Exchange Act and Rule 14f-1 thereunder.
Departed

Hao Tian

Director
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
Appointed

Stefan Dodov

Director
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
Appointed

Manuel C. Menendez III

Director
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
Appointed

Jiande Chen

Chief Executive Officer
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
Jiande Chen will replace Zikang Wu as Chief Executive Officer of the Company and chairman of the Board.
Departed

Zikang Wu

Director
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
Appointed

Jiande Chen

Director
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
Departed

Zixun Jin

Director
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
Appointed

Xiaocheng Peng

Director
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
Xiaocheng Peng, will become the permanent chief financial officer of the Company and non-independent director.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Xiaocheng Peng was appointed as Chief Financial Officer at Healthcare AI Acquisition Corp..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
Xiaocheng Peng, will become the permanent chief financial officer of the Company and non-independent director.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Nat Y Chan was appointed as Director at Healthcare AI Acquisition Corp..

Action
appointed
Role
Director
Exact text from the filing
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Yuerong Tan resigned as Director at Healthcare AI Acquisition Corp..

Action
resigned
Role
Director
Exact text from the filing
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jiande Chen was appointed as Chairman of the Board at Healthcare AI Acquisition Corp..

Action
appointed
Role
Chairman of the Board
Exact text from the filing
Jiande Chen will replace Zikang Wu as Chief Executive Officer of the Company and chairman of the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Zikang Wu resigned as Chief Executive Officer at Healthcare AI Acquisition Corp..

Action
resigned
Role
Chief Executive Officer
Exact text from the filing
Zikang Wu shall resign as chief executive officer, to be effective upon the expiration of all applicable waiting periods under Section 14(f) of the Exchange Act and Rule 14f-1 thereunder.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Hao Tian resigned as Director at Healthcare AI Acquisition Corp..

Action
resigned
Role
Director
Exact text from the filing
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Stefan Dodov was appointed as Director at Healthcare AI Acquisition Corp..

Action
appointed
Role
Director
Exact text from the filing
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Manuel C. Menendez III was appointed as Director at Healthcare AI Acquisition Corp..

Action
appointed
Role
Director
Exact text from the filing
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jiande Chen was appointed as Chief Executive Officer at Healthcare AI Acquisition Corp..

Action
appointed
Role
Chief Executive Officer
Exact text from the filing
Jiande Chen will replace Zikang Wu as Chief Executive Officer of the Company and chairman of the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Zikang Wu resigned as Director at Healthcare AI Acquisition Corp..

Action
resigned
Role
Director
Exact text from the filing
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jiande Chen was appointed as Director at Healthcare AI Acquisition Corp..

Action
appointed
Role
Director
Exact text from the filing
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Zixun Jin resigned as Director at Healthcare AI Acquisition Corp..

Action
resigned
Role
Director
Exact text from the filing
The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Xiaocheng Peng was appointed as Director at Healthcare AI Acquisition Corp..

Action
appointed
Role
Director
Exact text from the filing
Xiaocheng Peng, will become the permanent chief financial officer of the Company and non-independent director.
View on SEC.gov
Source: SEC EDGAR
accession 0001477932-23-009381
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.